Public health projects for preventing the recurrence of neural tube defects in the United States

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 85, Issue 11, 2009, Pages 935-938

  Collins, Julianne S ^a   Canfield, Mark A ^b   Pearson, Kay ^c   Kirby, Russell S ^d   Case, Amy P ^b   Mai, Cara T ^e   Major, Judy ^f   Mulinare, Joe ^e  

^a GREENWOOD GENETIC CENTER   (United States)

^b TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^c OKLAHOMA STATE DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^f Fullerton Genetics at Mission Hospitals   (United States)

Author keywords

Anencephaly; Folic acid; Neural tube defect; Prevention; Recurrence; Spina bifida

Indexed keywords

FOLIC ACID;

ARTICLE; BIRTH DEFECT; CONFIDENTIALITY; DISEASE SURVEILLANCE; FEMALE; FUNDING; HEALTH CARE COST; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PRIVACY; PUBLIC HEALTH SERVICE; PUERTO RICO; RECURRENT DISEASE; UNITED STATES;

FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; POPULATION SURVEILLANCE; PREGNANCY; PUBLIC HEALTH; RECURRENCE; UNITED STATES;

EID: 71049190170     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20619     Document Type: Article

References (17)

1. Bastani R, Maxwell AE, Bradford C, et al. 1999. Tailored risk notification for women with a family history of breast cancer. Prev Med 29:355-364.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
3. Canfield MA, Anderson JL, Waller DK, et al. 2002. Folic acid awareness and use among women with a history of a neural tube defect pregnancy-Texas, 2000-2001. MMWR Recomm Rep 51:16-19.
4. Canfield MA, Honein MA, Yuskiv N, et al. 2006. National estimates and race/ethnic-specific variation of selected Major birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 76:747-756. (Pubitemid 44777830)
5. Centers for Disease Control. 1991. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. MMWR Morb Mortal Wkly Rep 40:513-516.
6. Centers for Disease Control. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 41(RR-14).
7. Centers for Disease Control and Prevention. 2000. Neural tube defect surveillance and folic acid intervention-Texas-Mexico Border, 1993-1998. MMWR Morb Mortal Wkly Rep 49:1-4.
8. Cowchock S, Ainbender E, Prescott G, et al. 1980. The recurrence risk for neural tube defects in the United States: a collaborative study. Am J Med Genet 5:309-314. (Pubitemid 10004731)
9. Dean JH, Collins JS, Clary NJ, Stevenson RE. 2007. Preventing the recurrence of neural tube defects in South Carolina. Proc Greenwood Genet Center 26:40-44.
10. Grosse SD, Collins JS. 2007. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol 79:737-742. (Pubitemid 350271820)
11. Needleman C, Connally LB. 2003. Long-term impact of worker notification: qualitative assessment of a community-based notification and screening program in Augusta. Georgia Am J Ind Med 44:113-123. (Pubitemid 36917824)
12. Ouyang L, Grosse SD, Armour BS, Waitzman NJ. 2007. Health care expenditures of children and adults with spina bifida in a privately insured US population. Birth Defects Res A Clin Mol Teratol 79:552-558. (Pubitemid 47068191)
13. Rinsky-Eng J, Miller L. 2002. Knowledge, use, and education regarding folic acid supplementation: continuation study of women in Colorado who had a pregnancy affected by a neural tube defect. Teratology 66:S29-S31.
14. Sherwood NE, Jeffery RW, Pronk NP, et al. 2006. Mail and phone interventions for weight loss in a managed-care setting: weigh-to-be 2-year outcomes. Int J Obes (Lond) 30:1565-1573.
15. Squires SG, MacDonald DM, Scott JW, et al. 2003. Evaluation of Nova Scotia's hepatitis C risk notification program. Can Commun Dis Rep 29:61-65.
16. Williams JL, Abelman SM, Fassett EM, et al. 2006. Health care provider knowledge and practices regarding folic acid, United States, 2002-2003. Matern Child Health J 10:S67-S72.
17. Wong D, Berman SM, Furness BW, et al. 2005. Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities. Sex Transm Dis 32:194-198. (Pubitemid 40271274)